The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...

The US Food and Drug Administration has approved a new nasal spray for depression treatment. Known as Spravato and ...

Since October 2020 – when the Health Sciences Authority (HSA) first authorized sale of an esketamine nasal spray for serious depression – five psychiatrists who used the therapy on their ...

Since October 2020 – when the Health Sciences Authority (HSA) first authorised sale of an esketamine nasal spray for serious depression – five psychiatrists who used the therapy on their ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato ... through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster for Janssen ...

Esketamine, branded as Spravato, is a nasal spray that works on different neurotransmitter systems in the brain than most other antidepressants. Arguably called “one of the most important ...

"This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers hope for the millions of people affected by TRD," he added. Analysts at ...

SPRAVATO® (Esketamine): SPRAVATO® is an innovative treatment for treatment-resistant depression or depression with suicidal thoughts or actions. Administered under medical supervision, this ...

In other words, the details of Musk's ketamine use as of this writing were unknown, including how often (if at all anymore), under what circumstances exactly and via what method (spray, powder, liquid ...

Why was the FDA approval of esketamine so controversial among many researchers? Researchers Mark Horowitz and Joanna Moncrieff, both psychiatrists, noted (in the British Journal of Psychiatry in ...